Erik Wiberg
EVP
CORPORATE DEVELOPMENT
Coherus Biosciences
United States of America
Biography
Mr. Wiberg joined Coherus in 2017 with more than 30 years of experience, including more than 18 years in various business development and corporate finance roles at biopharmaceutical companies, and 13 years in healthcare investment banking and equity research. Mr. Wiberg has extensive experience in corporate development, completing numerous out-licensing, in-licensing, merger and acquisition, and financing transactions and research & development collaborations that achieved corporate priorities and created significant value for shareholders in several small and large-cap pharmaceutical companies. Before joining Coherus, Mr. Wiberg was most recently Senior Vice President, Strategy and Corporate Development at Anacor Pharmaceuticals, Inc. a company acquired by Pfizer in 2016 for $5.2 billion. He has also held leadership positions in corporate strategy, new product planning and portfolio management. Mr. Wiberg earned his dual degree in business and engineering from University of Pennsylvania, where he attended the Wharton School of Business and earned his Bachelor of Science in Economics, dual major in Finance and Accounting, and the School of Engineering and Applied Science where he earned his Bachelor of Applied Science with a major in Computer Science Engineering.
Research Interest
Business and economics